These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
5. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]. Jia HL; Xing XJ; Ye QH; Qin LX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617 [TBL] [Abstract][Full Text] [Related]
6. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma]. Zhao XY; Li N; Ding HG; Jiang FF Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. Nakamura S; Nouso K; Sakaguchi K; Ito YM; Ohashi Y; Kobayashi Y; Toshikuni N; Tanaka H; Miyake Y; Matsumoto E; Shiratori Y Am J Gastroenterol; 2006 Sep; 101(9):2038-43. PubMed ID: 16848811 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma. Jingting J; Changping W; Ning X; yibei Z; Jun W; Mei J; Bin X; Peter NE; Xueguan Z J Clin Lab Anal; 2009; 23(4):213-8. PubMed ID: 19623644 [TBL] [Abstract][Full Text] [Related]
10. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R; Wang B; Ding H; Shen H; Li Y; Chen X Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [TBL] [Abstract][Full Text] [Related]
13. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma. Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers. Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452 [TBL] [Abstract][Full Text] [Related]
16. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand. Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurements of serum AFP, GPC-3 and HCCR for diagnosing hepatocellular carcinoma. Qiao SS; Cui ZQ; Gong L; Han H; Chen PC; Guo LM; Yu X; Wei YH; Ha SA; Kim JW; Jin ZT; Li S; Peng JR; Leng XS Hepatogastroenterology; 2011; 58(110-111):1718-24. PubMed ID: 21940340 [TBL] [Abstract][Full Text] [Related]
19. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252 [TBL] [Abstract][Full Text] [Related]
20. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]